Mohammad Saeed, MD
Psychosomatic Medicine · League City, TXNPI 1861515074
Payments from drug & device makers
Across 403 payments — averaging $22.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Supernus Pharmaceuticals, Inc.$656
- Corium, LLC$560
- Otsuka America Pharmaceutical, Inc.$495
- Indivior Inc.$464
- plus $3K from 27 others
What the payments were for
- Food & beverage$9,04199%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 58 | $1,860 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 68 | $1,600 |
| Supernus Pharmaceuticals, Inc. | 40 | $656 |
| Corium, LLC | 27 | $560 |
| Otsuka America Pharmaceutical, Inc. | 19 | $495 |
| Indivior Inc. | 20 | $464 |
| AbbVie(2 entities) | 27 | $454 |
| Ironshore Pharmaceuticals Inc. | 26 | $399 |
| Lundbeck LLC | 21 | $376 |
| Neurocrine Biosciences, Inc. | 11 | $376 |
| Alkermes, Inc. | 11 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $186 |
| Axsome Therapeutics, Inc. | 7 | $180 |
| Sunovion Pharmaceuticals Inc. | 9 | $168 |
| Adlon Therapeutics L.p. | 8 | $136 |
| Biosense Webster, Inc. | 2 | $135 |
| Neos Therapeutics, LP | 6 | $108 |
| Nevro Corp. | 2 | $99 |
| E.r. Squibb & Sons, L.L.C. | 4 | $89 |
| Bausch Health US, LLC | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $70 |
| Orexo US, Inc. | 3 | $57 |
| Neuronetics, Inc. | 4 | $46 |
| Noven Therapeutics, LLC | 2 | $42 |
| Tris Pharma Inc | 2 | $39 |
| Shire North American Group Inc | 2 | $38 |
| Almatica Pharma LLC | 2 | $32 |
| MDD US Operations, LLC | 2 | $31 |
| Impulse Dynamics (USA) Inc. | 1 | $29 |
| Biogen | 1 | $29 |
| Tempus AI, Inc | 1 | $27 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$557
- CAPLYTA$480
- INVEGA SUSTENNA$274
- QELBREE$139
- Azstarys$122
- INGREZZA$122
- Carto 3 System$103
- REXULTI$103
How this compares
Too few psychosomatic medicine providers in Texasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 23 | $35,103 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 163 | $31,204 |
| TrintellixVortioxetine Hydrobromide | 12 | $7,493 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 12 | $7,123 |
| QuviviqDaridorexant Hcl | 12 | $5,550 |
| Aripiprazole | 88 | $5,522 |
| Lurasidone Hcl | 17 | $4,588 |
| Doxepin Hcl | 63 | $4,215 |
| Lisdexamfetamine Dimesylate | 19 | $4,005 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 71 | $3,869 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 82 | $3,136 |
| Duloxetine Hcl | 148 | $1,500 |
| Bupropion XlBupropion Hcl | 114 | $1,379 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 35 | $1,360 |
| Hydroxyzine Hcl | 72 | $1,306 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,600 | $35,10323 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $186 | $7,49312 claims |
| Orexo US, Inc.Zubsolv | $57 | $7,12312 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $15 | $5,55012 claims |
| Almatica Pharma LLCSertraline Hcl | $32 | $888127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few psychosomatic medicine providers in Texason file to place this against a meaningful peer group, so we don't.
Other psychosomatic medicine in League City
- Priyamvada KhandheriaLubbock$978
- Dawn LagroneCarrollton$166
- Anis RashidHouston$155
- Mary CrutchfieldRockwall$125
- Mohammed AhmedArlington$113
- Victoria MartinRichardson$19
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.